{"name":"Teleflex Incorporated","slug":"teleflex","ticker":"TFX","exchange":"NYSE","domain":"teleflex.com","description":"Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is an American provider of specialty medical devices for a range of procedures in critical care and surgery. Teleflex has annual revenues of $2.4 billion, operations in 40 countries, and more than 15,000 employees. By 2011, the company had substantially realigned to focus on its current business as a medical-device manufacturer, having undergone several years of active acquisitions and divestitures. Teleflex has been associated with Irish corporate tax avoidance tools. Teleflex's chief executive officer (CEO) is Liam J. Kelly; Kelly is also the company's president and former chief operating officer.","hq":"Wayne, PA","founded":0,"employees":"15500","ceo":"Liam J. Kelly","sector":"Medical Devices","stockPrice":119.2,"stockChange":3.69,"stockChangePercent":3.19,"marketCap":"$5.3B","metrics":{"revenue":3000000000,"revenueGrowth":251.5,"grossMargin":56.4,"rdSpend":144781000,"netIncome":-905640000,"cash":378564000,"dividendYield":1.18,"peRatio":91,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"Arrow patent cliff ($100M at risk)","drug":"Arrow","type":"patent_expiry","sentiment":"negative"},{"date":"2026-06-01","label":"LMA patent cliff ($50M at risk)","drug":"LMA","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-22","type":"earnings","headline":"Teleflex Reports Fourth Quarter and Full Year 2023 Results","summary":"Teleflex reported fourth quarter and full year 2023 results, with revenue of $1.04 billion and adjusted earnings per share of $2.44.","drugName":"","sentiment":"neutral"},{"date":"2023-09-26","type":"deal","headline":"Teleflex Announces Agreement to Acquire ICU Medical","summary":"Teleflex announced an agreement to acquire ICU Medical, a leading manufacturer of medical devices, for approximately $5.62 billion.","drugName":"","sentiment":"positive"},{"date":"2023-06-01","type":"regulatory","headline":"Teleflex Receives FDA Clearance for New Anesthesia Product","summary":"Teleflex received FDA clearance for a new anesthesia product, expanding its portfolio of medical devices.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE0ta2prN0xyY2FQYUZoNlVuWkVFRmR0WHQ3cUh2cG01TEk1c2tUUEZkVWU4NkI5YkE2NjZCY1FtTDFsTWR2aDcwdW5yX2o5ZFprV2M3aWVwcEp0UU9MS1k3UXB4bGNsS2dmV0tNamJvckZQWXo3eV9JSlFlZDk?oc=5","date":"2026-03-27","type":"pipeline","source":"StocksToTrade","summary":"Teleflex Stock Rises as New Global Platform Enhances Planning Capabilities - StocksToTrade","headline":"Teleflex Stock Rises as New Global Platform Enhances Planning Capabilities","sentiment":"neutral"},{"date":"2026-03-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-17","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNQkRBRHhaUnVqbldnMUtuNUVUZk9XWURMTXN0aXJjXzB4aWxXaVhDc0dKUlJiN0FSVU1hQWQxbXJMSkE0UkIwTk5VOGpneWJyRWh4a2tUWGRacXhWNTdST1JRblJraE85V2ctTGl5bnlONnU0MmJDdXZ5OHF3U200UXdGbVZUdDduUVFJX01rMkhFRnZvVGVkQ1lrOTZFTlhHV0ROcmJqQVo?oc=5","date":"2026-02-27","type":"earnings","source":"Seeking Alpha","summary":"Teleflex Incorporated 2025 Q4 - Results - Earnings Call Presentation (NYSE:TFX) 2026-02-27 - Seeking Alpha","headline":"Teleflex Incorporated 2025 Q4 - Results - Earnings Call Presentation (NYSE:TFX) 2026-02-27","sentiment":"neutral"},{"date":"2026-02-27","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPaHhzZlRkVWFSazk1dDNmb19yYUU4MHB5a1F0MzJiZkNYQ25xT2FlXzJhOGV6bXRqSW5PWV9LS3N3UFdOT1YxNTRMMkhxVGFVcDgtTHdUMFZrSlg4VktOWGM2TWw5N3Z6c3BwNzZ6ZVhtY3AyMk80TFdZX1ZpbV80SmYxSzJJNzl5MU1sYTFLWlpTc1Axd1E2NmhhU0JSM1AzNno3TlFISU1HMkwzNjVUVnFB?oc=5","date":"2026-02-26","type":"pipeline","source":"Stock Titan","summary":"Teleflex starts multi-year cost cuts after strategic divestitures - Stock Titan","headline":"Teleflex starts multi-year cost cuts after strategic divestitures","sentiment":"neutral"},{"date":"2026-02-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxQNlpOTFdDTnpLMF9taS1vN09ISVJERkJwdHdWTEFjNDNOQkdSdW9YX0JDTVdYTWk0VEdEU0ktWGpyQXZZNll4eWVzUlhGQklYMktldjRqRGQzdHlxcGJ6SS01Z2xRazlqMkxiRFNMa3J1ZVd1RmZ5blBNMXR6ZVNJM1JGNkdmcThoaWxDa185SVJSVjRicnhpdDZaM2tuYmFIWnhwQ0thU1Q0c0tXYUozbUNaZGlRN2oybi15SUFmZXJxWE5fcWZlSkJNcnlINkRMQlliQ3p1UkpTUC05WmRoV1dQbHJxVG9OWVVOQTRrRGdERGxEUnc?oc=5","date":"2026-01-29","type":"pipeline","source":"PR Newswire","summary":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX - PR Newswire","headline":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX","sentiment":"neutral"},{"date":"2026-01-23","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE5oQndBQU92U182N3Myc0tIekNrYVFHeDBFOW1WaExpY19yaG9BZEhRa21BNFA0YVhVTVRwT1hFcFJxX0xDYjJObzJNUzlXdFRYRU03NkhVb1ZOdFRzRXRhcGtoZXBnVjRxSkE2c1B6bl9Cdk5wcXVRMi13?oc=5","date":"2025-12-10","type":"pipeline","source":"Seeking Alpha","summary":"Teleflex: Selling, But How Much? (NYSE:TFX) - Seeking Alpha","headline":"Teleflex: Selling, But How Much? (NYSE:TFX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOWUtOa1VCZkF2MzhrZXc3Wi1FWFpBdHZJNklYcVFjNEpNQ3BZeTZvTWtrX3hzOEg4SkN0Ym03em5Qd1EtMkxtZnlySmJmY2xPUGxxR0ZhbXp4YjlqeDVJRG5tM29iaFhGalZETWhqdlZUMnJSN0dWcnoxWVZqRTZkb3B6WTBfY0dhU0oydmY4YmV1d2syWUhjTi1Ubi11em1lN1NaQ2VRT0ptSUxoZVF3R3RENlJWSUdzRVE?oc=5","date":"2025-12-09","type":"pipeline","source":"Reuters","summary":"Medical device maker Teleflex to divest three units for $2.03 billion - Reuters","headline":"Medical device maker Teleflex to divest three units for $2.03 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOQ0pYVjgwM3BLV2dodFBqeEhWTG1MM0trdDZ6QUdmaEtMVkRpQi01bkxWSGJnSWplcmhuUnJ0MXphV3d6OHB3ZDZsTVAyQ013MEhtUHBJM2VHQS1LZ1NLQjc3cTMwVnQ5Z3lSX3RZWHJsa0xTYi1hSTc0ZVZYRHBjZw?oc=5","date":"2025-12-09","type":"pipeline","source":"StocksToTrade","summary":"Teleflex’s Latest Moves: What’s Next for TFX Stock?​ - StocksToTrade","headline":"Teleflex’s Latest Moves: What’s Next for TFX Stock?​","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOTGpGaHR6U0lHaVJoZmE5SlVWWEpsY0cwRlU1YzUyMzduRHExR3Q0WG13bHp6bmNmWlRtaXpJXzJ6aGdwd2NWS1dob2pEQmNGMGNLc0FKZ2F4RWY4YW1rTk1qeW9wbS12YjBKSVQ0SDBVOFZxRGdNOEhkdnNYRW1BQ29fendreHVHSUs0WS1ZTmVPVTZVNTZrTWlEN3p3RDdidTUzdEFGT3A?oc=5","date":"2025-12-09","type":"pipeline","source":"Medical Design & Outsourcing","summary":"Teleflex Medical OEM is getting sold to private equity firms - Medical Design & Outsourcing","headline":"Teleflex Medical OEM is getting sold to private equity firms - Medical Design & Outsourcing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxQSUhKeTBUYTJ2TVdXQ01sWUdXUzM3UHlnTVdla292VXpaOElBdndJblI3QzZyb3E4OUZHVWNjRTdiUkRpa0JoT1J3OVY2Z0Q0Q01qM1JEdXhpZ1F3ODd5SWlHejMxWnBjUzQ5ei1tVWIzYmxvekEydU01WjVfVFk4MnZsb2tpaTJ3MVVtVjZKWkN0TlExVlhsTEs0MEFXLWxDRHhtWktTaDRXV1FjTk9ueG5WZWNjWTk2Sm5wZGNFMDE4d1NCVVJua05GbGtwTDJUUURtdHl1TlZaaWdVUV9rekNJYks1WklQbWlncFNrMzh3RFFaSVNsSGlKZE4?oc=5","date":"2025-12-09","type":"pipeline","source":"GlobeNewswire","summary":"Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion - GlobeNewswire","headline":"Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNY3dhZlVieGlmSzlnNWZXRkxMRWJSVEtlNmhTaDNVSk1hS2x4UWsxM1NWcDVGUkJ6RGp5dkNSMGlNUDYyR1NBY2NybWJnakJscW9zamtqMUN0YnY3d1lNaVNQREgyenh3ZmsweVgwZDBQazhJTWFyaFNUUFZ3RG9tUml3RkJXSjNG?oc=5","date":"2025-09-14","type":"pipeline","source":"Seeking Alpha","summary":"Teleflex In 2025: A Company Trying To Reset (NYSE:TFX) - Seeking Alpha","headline":"Teleflex In 2025: A Company Trying To Reset (NYSE:TFX)","sentiment":"neutral"}],"patents":[{"drugName":"Arrow","drugSlug":"arrow","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":100000000},{"drugName":"LMA","drugSlug":"laryngeal-mask-airway","patentNumber":"","type":"Patent Cliff","expiryDate":"2026-06-01","territory":"US","annualRevenue":50000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":["Medtronic","Stryker","Becton Dickinson"],"therapeuticFocus":["Anesthesia","Respiratory Care","Surgical Specialties"],"financials":{"source":"sec_edgar","revenue":1992713000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":1992713000,"period":"2025-12-31"},{"value":566946000,"period":"2025-09-28"},{"value":442525000,"period":"2025-06-29"},{"value":414258000,"period":"2025-03-30"},{"value":3047324000,"period":"2024-12-31"},{"value":426200000,"period":"2024-09-29"}],"grossProfit":1120754000,"grossProfitHistory":[],"rdSpend":144781000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-905640000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":378564000,"cashHistory":[],"totalAssets":6947239000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":119.2,"previousClose":115.51,"fiftyTwoWeekHigh":138.93,"fiftyTwoWeekLow":100.18,"fiftyTwoWeekRange":"100.18 - 138.93","fiftyDayAverage":110.48,"twoHundredDayAverage":117.7,"beta":0.83,"enterpriseValue":7523207168,"forwardPE":11.8,"priceToBook":1.69,"priceToSales":2.64,"enterpriseToRevenue":3.77,"enterpriseToEbitda":16.04,"pegRatio":0,"ebitda":469188000,"ebitdaMargin":23.5,"freeCashflow":12825875,"operatingCashflow":340676992,"totalDebt":2822424064,"debtToEquity":90.3,"currentRatio":2.54,"returnOnAssets":2.6,"returnOnEquity":1.6,"analystRating":"2.9 - Hold","recommendationKey":"hold","numberOfAnalysts":9,"targetMeanPrice":130.22,"targetHighPrice":147,"targetLowPrice":115,"dividendRate":1.36,"payoutRatio":1.04,"fiveYearAvgDividendYield":0.68,"exDividendDate":1772755200,"insiderHeldPercent":0.3,"institutionHeldPercent":108.2,"sharesOutstanding":44200562,"floatShares":44032600,"sharesShort":2291616,"shortRatio":2.34,"shortPercentOfFloat":5.2,"epsTrailing":1.31,"epsForward":10.14,"revenuePerShare":44.66,"bookValue":70.7,"officers":[{"age":65,"name":"Mr. Stuart A. Randle","title":"CEO, Interim President & Director"},{"age":51,"name":"Mr. Daniel V. Logue J.D.","title":"Corporate VP, General Counsel & Secretary"},{"age":57,"name":"Mr. John R. Deren","title":"Executive VP & CFO"},{"age":null,"name":"Mr. Timothy F. Duffy","title":"VP & Chief Information Officer"},{"age":null,"name":"Mr. Lawrence Soren Keusch","title":"Vice President of Investor Relations & Strategy Development"},{"age":null,"name":"Mr. Howard  Cyr","title":"Corporate VP & Chief Compliance Officer"},{"age":60,"name":"Mr. Cameron P. Hicks","title":"Corporate Vice President of Human Resources & Communications"},{"age":null,"name":"Mr. James  Ferguson","title":"President & GM of Surgical"}],"industry":"Medical Instruments & Supplies","irWebsite":"http://www.teleflex.com/en/investor/corporateProfile/index.html","website":"https://www.teleflex.com","phone":"610-225-6800"}}